Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial. New ...
Recent SQL Server 2025, Azure SQL, SSMS 22 and Fabric announcements highlight new event streaming and vector search capabilities, plus expanding monitoring and ontology tooling -- with tradeoffs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results